Ani Pharmaceuticals Ratios (2010-2026) | ANIP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	54.11%	53.11%	44.36%	46.85%	52.21%	60.76%	61.45%	64.69%	63.72%	63.51%	59.42%	64.23%	58.20%	57.48%	57.87%	62.95%	64.70%	59.01%	59.42%	60.59%
EBT Margin (Quarter)	-37.43%	-13.70%	-50.65%	-40.16%	-25.48%	-14.58%	-6.08%	2.03%	4.50%	8.73%	0.72%	18.43%	-1.66%	-21.23%	-7.22%	10.14%	4.98%	14.84%	12.74%	16.94%
EBIT Margin (Quarter)	-31.99%	-6.84%	-38.94%	-29.77%	-17.48%	-5.96%	1.93%	9.27%	10.64%	13.61%	5.11%	14.78%	3.74%	-13.83%	-2.30%	13.29%	6.57%	15.91%	14.07%	16.38%
EBITDA Margin (Quarter)	-31.99%	-6.84%	-38.94%	-29.77%	-17.48%	-5.96%	1.93%	9.27%	10.64%	13.61%	5.11%	14.78%	3.74%	-13.83%	-2.30%	13.29%	6.57%	15.91%	14.07%	16.38%
Operating Margin (Quarter)	-31.99%	-6.84%	-38.94%	-29.77%	-17.48%	-5.96%	1.93%	9.27%	10.64%	13.61%	5.11%	14.78%	3.74%	-13.83%	-2.30%	13.29%	6.57%	15.91%	14.07%	16.38%
Net Margin (Quarter)	-29.01%	-8.54%	-39.93%	-31.85%	-20.76%	-10.74%	-4.93%	0.97%	5.01%	7.23%	0.57%	12.95%	-1.95%	-16.57%	-5.61%	7.75%	3.85%	11.53%	11.13%	12.42%
FCF Margin (Quarter)	-2.41%	-7.30%	-20.20%	-29.77%	-19.63%	1.38%	-8.00%	19.38%	17.86%	24.62%	33.92%	12.40%	6.96%	14.07%	0.14%	16.50%	36.90%	13.94%	11.79%	22.02%
Efficiency
Inventory Average (Quarter)	69.25M	67.40M	71.69M	82.42M	91.78M	102.87M	105.34M	104.50M	103.99M	105.46M	108.89M	112.52M	119.64M	136.75M	142.41M	137.09M	137.86M	142.40M	144.77M	143.27M
Assets Average (Quarter)	472.00M	475.31M	621.03M	758.22M	748.09M	745.22M	749.60M	762.66M	812.28M	874.63M	897.17M	909.47M	917.64M	1,104.07M	1,285.92M	1,288.45M	1,317.71M	1,375.58M	1,424.26M	1,431.17M
Equity Average (Quarter)	197.81M	191.66M	94.13M	193.97M	193.17M	-48.69M	155.63M	207.52M	5.57M	0.00M	0.00M	-31.16M	235.08M	521.70M	258.12M	268.20M	227.10M	214.48M	523.27M	551.51M
Invested Capital (Quarter)	302.54M	300.55M	296.87M	690.33M	293.76M	205.11M	700.90M	307.38M	295.50M	294.75M	294.00M	230.92M	825.00M	835.90M	328.31M	851.99M	242.04M	822.69M	853.54M	871.05M
Asset Utilization Ratio (Quarter)	0.36	0.36	0.28	0.30	0.34	0.38	0.42	0.47	0.49	0.51	0.54	0.57	0.59	0.50	0.48	0.52	0.57	0.60	0.62	0.65
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)	1.07	1.06	-91.67	0.73	-60.59	-3.10	0.71	25.72	0.16M	0.15M	0.14M	-4.57	0.54	0.61	59.56	0.58	-4.09	0.62	0.57	0.54
Debt Ratio (Quarter)	0.43	0.43	0.37	0.39	0.38	0.39	0.38	0.37	0.36	0.35	0.32	0.31	0.31	0.24	0.25	0.24	0.23	0.22	0.21	0.21
Equity Ratio (Quarter)	0.40	0.41	0.00	0.53	-0.01	-0.13	0.53	0.01	0.00	0.00	0.00	-0.07	0.58	0.40	0.00	0.41	-0.06	0.36	0.38	0.40
Times Interest Earned (Quarter)
Dividends & Payouts
FCF Payout Ratio (Quarter)			-0.02	-0.02	-0.03	0.35	-0.05	0.02	0.02	0.01	0.01	0.02	0.04	0.02	1.57	0.01	0.01	0.01
Valuation
Enterprise Value (Quarter)	-24.26M	-15.25M	-105.30M	-81.91M	-68.39M	-61.28M	-53.23M	-67.76M	-161.71M	-193.08M	-221.12M	-228.60M	-240.11M	-145.02M	-144.89M	-149.84M	-217.83M	-262.65M	-285.62M	-311.21M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-2.45%	-4.03%	-7.46%	-9.14%	-9.11%	-9.17%	-5.43%	-0.97%	2.77%	5.68%	6.25%	7.43%	6.45%	1.28%	0.05%	0.60%	1.41%	6.51%	9.69%	10.39%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.00%	-0.01%	66.76%	93.75%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Ani Pharmaceuticals Ratios (2010-2026) | ANIP

Create an account

Sign In

Reset Password